Natalia Navarro

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

High Throughput

Childhood Cancer

Top Venues

Science advances

Cellular and molecular life sciences : CMLS

This page only lists publications with an associated author ORCID identifier.

Publications

Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Sara G Danielli, Ermelinda Porpiglia, Andrea J De Micheli, Natalia Navarro, Michael J Zellinger, Ingrid Bechtold, Samanta Kisele, Larissa Volken, Joana G Marques, Stephanie Kasper, Peter Karl Bode, Anton G Henssen, Dennis Gurgen, Olivier Delattre, Didier Surdez, Josep Roma, Peter Bühlmann, Helen M Blau, Marco Wachtel, Beat W Schäfer
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance. Science advances 9 (6) (2023)
Natalia Navarro, Carla Molist, Júlia Sansa-Girona, Patricia Zarzosa, Gabriel Gallo-Oller, Guillem Pons, Ainara Magdaleno, Gabriela Guillén, Raquel Hladun, Marta Garrido, Miguel F Segura, Lourdes Hontecillas-Prieto, Enrique de Álava, Berta Ponsati, Jimena Fernández-Carneado, Ana Almazán-Moga, Mariona Vallès-Miret, Josep Farrera-Sinfreu, Josep Sánchez de Toledo, Lucas Moreno, Soledad Gallego, Josep Roma
Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma. Cellular and molecular life sciences : CMLS 79 (11) (2022)